The influence of glutamatergic antagonism on motor variability, and comparison to findings in schizophrenia patients

Objective The primary aim of this explorative study was to investigate the influence of the glutamatergic N‐methyl‐d‐aspartate (NMDA) receptor antagonist memantine on motor activity in healthy subjects. Secondarily, we wanted to compare these data to findings in a sample of schizophrenia patients. Methods The healthy subjects acted as their own controls in an open‐within‐subject design. Motor activity was recorded with an actigraph worn for 24 h in the drug‐free, and steady‐state memantine conditions, respectively. Motor activity levels for 1‐min intervals were analysed by means of both linear and nonlinear methods. The schizophrenia patients were monitored only once, without memantine manipulation. Results The root mean square successive differences (RMSSD) and the RMSSD/SD ratio were increased by memantine, and memantine was also associated with lower autocorrelation (lag 1) but in recordings from the right arm only. These movement patterns partly corresponded to those found in a sample of drug‐treated schizophrenia patients. Total activity level, standard deviation (SD) and sample entropy were not significantly different in the memantine versus drug‐free condition. Conclusion The findings suggest a role for the NMDA receptor in the regulation of motor activity in healthy individuals as memantine increased the variability in the motor recordings and the alterations between adjacent motor recordings. It is suggested that the findings may be relevant to the role played by glutamate and the NMDA receptor functioning to the motor disturbances in schizophrenia.

[1]  Ole Bernt Fasmer,et al.  Nonlinear Analysis of Motor Activity Shows Differences between Schizophrenia and Depression: A Study Using Fourier Analysis and Sample Entropy , 2011, PloS one.

[2]  A. Korchounov,et al.  Postsynaptic nigrostriatal dopamine receptors and their role in movement regulation , 2010, Journal of Neural Transmission.

[3]  Fred Holsten,et al.  Actigraphic registration of motor activity reveals a more structured behavioural pattern in schizophrenia than in major depression , 2010, BMC Research Notes.

[4]  E. Shorter,et al.  Catatonia is not schizophrenia: Kraepelin's error and the need to recognize catatonia as an independent syndrome in medical nomenclature. , 2010, Schizophrenia bulletin.

[5]  Werner Strik,et al.  Quantitative Motor Activity Differentiates Schizophrenia Subtypes , 2009, Neuropsychobiology.

[6]  S. Kapur,et al.  The dopamine hypothesis of schizophrenia: version III--the final common pathway. , 2009, Schizophrenia bulletin.

[7]  A. Mikulecká,et al.  Different effects of two N-methyl-d-aspartate receptor antagonists on seizures, spontaneous behavior, and motor performance in immature rats , 2009, Epilepsy & Behavior.

[8]  John M. Davis,et al.  Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis , 2009, The Lancet.

[9]  P. Dazzan,et al.  Spontaneous movement disorders in antipsychotic-naive patients with first-episode psychoses: a systematic review , 2008, Psychological Medicine.

[10]  A. Schene,et al.  Is the Defined Daily Dose system a reliable tool for standardizing antipsychotic dosages? , 2008, International clinical psychopharmacology.

[11]  Suneil K. Kalia,et al.  NMDA receptors in clinical neurology: excitatory times ahead , 2008, The Lancet Neurology.

[12]  Steven M. Pincus,et al.  A noninvasive measure of negative-feedback strength, approximate entropy, unmasks strong diurnal variations in the regularity of LH secretion. , 2007, American journal of physiology. Endocrinology and metabolism.

[13]  D. Cuesta-Frau,et al.  Characterization of Sample Entropy in the Context of Biomedical Signal Analysis , 2007, 2007 29th Annual International Conference of the IEEE Engineering in Medicine and Biology Society.

[14]  W. Hulstijn,et al.  Psychomotor slowing in schizophrenia. , 2007, Schizophrenia bulletin.

[15]  Volkan Tuzcu,et al.  Decrease in the heart rate complexity prior to the onset of atrial fibrillation. , 2006, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[16]  B. Pleger,et al.  The NMDA antagonist memantine affects training induced motor cortex plasticity – a study using transcranial magnetic stimulation [ISRCTN65784760] , 2005, BMC Neuroscience.

[17]  Marc Laruelle,et al.  Mechanisms of action of second generation antipsychotic drugs in schizophrenia: insights from brain imaging studies , 2005, European Psychiatry.

[18]  W. Danysz,et al.  Effects of NMDA receptor channel blockers, MK-801 and memantine, on locomotor activity and tolerance to delay of reward in Wistar−Kyoto and spontaneously hypertensive rats , 2004, Behavioural pharmacology.

[19]  O. Andreassen,et al.  Memantine attenuates the increase in striatal preproenkephalin mRNA expression and development of haloperidol-induced persistent oral dyskinesias in rats , 2003, Brain Research.

[20]  T. Rammsayer.  NMDA Receptor Activity and the Transmission of Sensory Input into Motor Output in Introverts and Extraverts , 2003, The Quarterly journal of experimental psychology. B, Comparative and physiological psychology.

[21]  R. Tandon,et al.  Extrapyramidal Side Effects of Antipsychotic Treatment: Scope of Problem and Impact on Outcome , 2002, Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists.

[22]  Ioannis Ilias,et al.  Complexity and non-linear description of diurnal cortisol and growth hormone secretory patterns before and after sleep deprivation. , 2002, Endocrine regulations.

[23]  Jeffrey M. Hausdorff,et al.  Physionet: Components of a New Research Resource for Complex Physiologic Signals". Circu-lation Vol , 2000 .

[24]  J. Richman,et al.  Physiological time-series analysis using approximate entropy and sample entropy. , 2000, American journal of physiology. Heart and circulatory physiology.

[25]  A L Goldberger,et al.  Fractal correlation properties of R-R interval dynamics and mortality in patients with depressed left ventricular function after an acute myocardial infarction. , 2000, Circulation.

[26]  E. Esposito,et al.  Decreased chaos of midbrain dopaminergic neurons after serotonin denervation , 1999, Neuroscience.

[27]  C. Parsons,et al.  Memantine is a clinically well tolerated N-methyl-d-aspartate (NMDA) receptor antagonist—a review of preclinical data , 1999, Neuropharmacology.

[28]  O. Andreassen,et al.  Inhibition by memantine of the development of persistent oral dyskinesias induced by long‐term haloperidol treatment of rats , 1996, British journal of pharmacology.

[29]  R. Post,et al.  Ultra-Rapid and Ultradian Cycling in Bipolar Affective Illness , 1996, British Journal of Psychiatry.

[30]  C L Ehlers,et al.  Chaos and Complexity: Can It Help Us to Understand Mood and Behavior? , 1995 .

[31]  T. Tzschentke.  Glutamatergic mechanisms in different disease states: overview and therapeutical implications – An introduction , 2002, Amino Acids.

[32]  J. Overall,et al.  The semistructured BPRS interview and rating guide. , 1988, Psychopharmacology bulletin.